Prot #GO27819: A Randomized, Double Blind, Placebo-Controlled, Multicenter Phase II Study Evaluating the Efficacy and Safety Of Onartuzumab in Combination with Bevacizumab or Onartuzumab Monotherapy in Patients with Recurrent Glioblastoma

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/26/12 → 11/26/15

Funding

  • PPD Development (Prot #GO27819)
  • Genentech, Inc. (Prot #GO27819)